The July Brand Monitor by Pharmarack shows a healthy top-20 portfolio overall, with growth concentrated in several large brands and clear market-share gains. The standout is Mounjaro, while Mixtard and Monocef— Key observations 1. Mounjaro is the exceptional growth story.Mounjaro ranks #1 at 109.8 value, growing 157%, versus the anti-diabetic super-group growth of only 18%….
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
